MR-proADM as prognostic factor of outcome in COVID-19 patients

MR-proADM as prognostic factor of outcome in COVID-19 patients

Abstract Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-pr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Emanuela Sozio, Carlo Tascini, Martina Fabris, Federica D’Aurizio, Chiara De Carlo, Elena Graziano, Flavio Bassi, Francesco Sbrana, Andrea Ripoli, Alberto Pagotto, Alessandro Giacinta, Valentina Gerussi, Daniela Visentini, Paola De Stefanis, Maria Merelli, Kordo Saeed, Francesco Curcio
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Medicine
R
Science
Q
Accès en ligne:https://doaj.org/article/a8a013a15cbd41c2a6ba4ba6f7e62b67
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/a8a013a15cbd41c2a6ba4ba6f7e62b67

Documents similaires